Minaris Regenerative Medicine stands as a prominent worldwide contract development and manufacturing organization (CDMO) focused on producing cell and gene therapy products. For over two decades, we have provided clinical and commercial manufacturing services, development solutions, and technologies with exceptional quality and dependability. At Minaris Regenerative Medicine, we are dedicated to assembling and further cultivating exceptionally talented, proficient, and committed specialists with diverse expertise relevant to gene and cell therapy manufacturing and development.